Literature DB >> 5923592

Glucose tolerance test. Variability in pregnant and nonpregnant women.

J B O'Sullivan, C M Mahan.   

Abstract

Entities:  

Mesh：

Year:  1966        PMID： 5923592     DOI： 10.1093/ajcn/19.5.345

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN： 0002-9165            Impact factor:   7.045


× No keyword cloud information.
  7 in total

1.  Nonparametric regression to the mean.

Authors:  Hans-Georg Muller; Ian Abramson; Rahman Azari
Journal:  Proc Natl Acad Sci U S A       Date:  2003-08-05       Impact factor: 11.205

Review 2.  Periodic health examination, 1992 update: 1. Screening for gestational diabetes mellitus. Canadian Task Force on the Periodic Health Examination.

Authors: 
Journal:  CMAJ       Date:  1992-08-15       Impact factor: 8.262

Review 3.  Impaired glucose tolerance.

Authors:  J S Yudkin; K G Alberti; D G McLarty; A B Swai
Journal:  BMJ       Date:  1990-09-01

4.  Imprecision of new criteria for the oral glucose tolerance test.

Authors:  V Massari; E Eschwège; A J Valleron
Journal:  Diabetologia       Date:  1983-02       Impact factor: 10.122

5.  Pulmonary excretion of carbon monoxide in the human infant as an index of bilirubin production. IIb. Evidence for the possible effect of maternal prenatal glucose metabolism on postnatal bilirubin production in a mixed population of infants.

Authors:  D K Stevenson; C R Ostrander; R S Cohen; J D Johnson; H C Schwartz
Journal:  Eur J Pediatr       Date:  1981-11       Impact factor: 3.183

6.  Influence of the time of day and fasting duration on glucose level following a 1-hour, 50-gram glucose challenge test in pregnant women.

Authors:  Panchalli Wang; Mei-Chun Lu; Cheng-Wei Yu; Yuan-Horng Yan
Journal:  PLoS One       Date:  2014-11-13       Impact factor: 3.240

7.  Approaches to screening for hyperglycaemia in pregnant women during and after the COVID-19 pandemic.

Authors:  C L Meek; R S Lindsay; E M Scott; C E Aiken; J Myers; R M Reynolds; D Simmons; J M Yamamoto; D R McCance; H R Murphy
Journal:  Diabet Med       Date:  2020-09-21       Impact factor: 4.359
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.